Thad W Vickery1, Vijay R Ramakrishnan2, Jeffrey D Suh3. 1. Department of Head and Neck Surgery, David Geffen School of Medicine, University of California Los Angeles, 10833 Le Conte Ave., CHS 62-132, Los Angeles, CA, 90095-1624, USA. 2. Department of Otolaryngology-Head and Neck Surgery, University of Colorado, 12631 E 17th Ave., B205, Aurora, CO, 80045, USA. 3. Department of Head and Neck Surgery, David Geffen School of Medicine, University of California Los Angeles, 10833 Le Conte Ave., CHS 62-132, Los Angeles, CA, 90095-1624, USA. JeffSuh@Mednet.UCLA.edu.
Abstract
PURPOSE OF REVIEW: Staphylococcus aureus (S. aureus) is correlated with the development of persistent severe inflammatory disease of the upper airway including chronic rhinosinusitis with nasal polyps (CRSwNP). The presence of S. aureus is associated with atopic disease including allergic rhinitis and atopic dermatitis and is associated with poor outcomes. RECENT FINDINGS: Several different strains of S. aureus generate different toxins and gene products that can account for organism pathogenicity. S. aureus bacteria and its antigens shape the bacterial and fungal microbiome and the mucosal niche which generates host responses that can account for inflammation. The multiple disease phenotypes and molecular endotypes seen in CRSwNP can be characterized by T-helper cell environment within the inflammatory milieu, the presence of epithelial barrier dysfunction, aberrant eicosanoid metabolism, poor wound healing, and dysfunctional host-bacteria interactions which lead to recalcitrant disease and worse surgical outcomes. Understanding the pathomechanisms that S. aureus utilizes to promote nasal polyp formation, prolonged tissue inflammation, and bacterial dysbiosis are essential in our efforts to identify new therapeutic approaches to resolve this chronic inflammatory process.
PURPOSE OF REVIEW: Staphylococcus aureus (S. aureus) is correlated with the development of persistent severe inflammatory disease of the upper airway including chronic rhinosinusitis with nasal polyps (CRSwNP). The presence of S. aureus is associated with atopic disease including allergic rhinitis and atopic dermatitis and is associated with poor outcomes. RECENT FINDINGS: Several different strains of S. aureus generate different toxins and gene products that can account for organism pathogenicity. S. aureus bacteria and its antigens shape the bacterial and fungal microbiome and the mucosal niche which generates host responses that can account for inflammation. The multiple disease phenotypes and molecular endotypes seen in CRSwNP can be characterized by T-helper cell environment within the inflammatory milieu, the presence of epithelial barrier dysfunction, aberrant eicosanoid metabolism, poor wound healing, and dysfunctional host-bacteria interactions which lead to recalcitrant disease and worse surgical outcomes. Understanding the pathomechanisms that S. aureus utilizes to promote nasal polyp formation, prolonged tissue inflammation, and bacterial dysbiosis are essential in our efforts to identify new therapeutic approaches to resolve this chronic inflammatory process.
Authors: Anthony A Prince; Jacob D Steiger; Ayesha N Khalid; Laurel Dogrhamji; Christine Reger; Steven Eau Claire; Alexander G Chiu; David W Kennedy; James N Palmer; Noam A Cohen Journal: Am J Rhinol Date: 2008 May-Jun
Authors: N Zhang; P Gevaert; T van Zele; C Perez-Novo; J Patou; G Holtappels; P van Cauwenberge; C Bachert Journal: Rhinology Date: 2005-09 Impact factor: 3.681
Authors: Vijay R Ramakrishnan; Leah J Hauser; Leah M Feazel; Diana Ir; Charles E Robertson; Daniel N Frank Journal: J Allergy Clin Immunol Date: 2015-03-26 Impact factor: 10.793
Authors: Vijay R Ramakrishnan; Leah M Feazel; Sarah A Gitomer; Diana Ir; Charles E Robertson; Daniel N Frank Journal: PLoS One Date: 2013-12-30 Impact factor: 3.240
Authors: Whitney W Stevens; Anju T Peters; Lydia Suh; James E Norton; Robert C Kern; David B Conley; Rakesh K Chandra; Bruce K Tan; Leslie C Grammer; Kathleen E Harris; Roderick G Carter; Atsushi Kato; Margrit Urbanek; Robert P Schleimer; Kathryn E Hulse Journal: Immun Inflamm Dis Date: 2015-02-12
Authors: Ioannis Koutsourelakis; Ashleigh Halderman; Syed Khalil; Lauren E Hittle; Emmanuel F Mongodin; Andrew P Lane Journal: BMC Infect Dis Date: 2018-08-30 Impact factor: 3.090
Authors: Anika Kaura; Rishi Shukla; Abigail Lamyman; Robert Almeyda; Mark Draper; Pablo Martinez-Devesa; Ali Qureishi Journal: Turk Arch Otorhinolaryngol Date: 2020-12-01
Authors: Samuel J M Hale; Brett Wagner Mackenzie; Christian A Lux; Kristi Biswas; Raymond Kim; Richard G Douglas Journal: Front Pharmacol Date: 2022-06-13 Impact factor: 5.988